ZFP3
geneOn this page
Also known as FLJ30726ZNF752
Summary
ZFP3 (ZFP3 zinc finger protein, HGNC:12861) is a protein-coding gene on chromosome 17p13.2, encoding Zinc finger protein 3 homolog (Q96NJ6). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 124961 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 55 total
- Druggable target: yes
- MANE Select transcript:
NM_153018
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12861 |
| Approved symbol | ZFP3 |
| Name | ZFP3 zinc finger protein |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ30726, ZNF752 |
| Ensembl gene | ENSG00000180787 |
| Ensembl biotype | protein_coding |
| OMIM | 194480 |
| Entrez | 124961 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000318833, ENST00000902904
RefSeq mRNA: 1 — MANE Select: NM_153018
NM_153018
CCDS: CCDS11067
Canonical transcript exons
ENST00000318833 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001278622 | 5078467 | 5078575 |
| ENSE00001305992 | 5091497 | 5096374 |
Expression profiles
Bgee: expression breadth ubiquitous, 221 present calls, max score 92.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.5456 / max 272.7187, expressed in 1275 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 159013 | 6.2417 | 1263 |
| 159011 | 0.1565 | 71 |
| 159012 | 0.1474 | 67 |
Top tissues by expression
245 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cardiac muscle of right atrium | UBERON:0003379 | 92.64 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 92.26 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 91.94 | silver quality |
| bronchial epithelial cell | CL:0002328 | 89.50 | gold quality |
| bronchus | UBERON:0002185 | 88.80 | gold quality |
| kidney epithelium | UBERON:0004819 | 87.99 | silver quality |
| germinal epithelium of ovary | UBERON:0001304 | 86.39 | gold quality |
| ileal mucosa | UBERON:0000331 | 86.03 | gold quality |
| secondary oocyte | CL:0000655 | 85.23 | gold quality |
| tibialis anterior | UBERON:0001385 | 84.69 | silver quality |
| endothelial cell | CL:0000115 | 84.04 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.76 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.58 | silver quality |
| deltoid | UBERON:0001476 | 83.32 | silver quality |
| myocardium | UBERON:0002349 | 82.99 | silver quality |
| vastus lateralis | UBERON:0001379 | 81.34 | silver quality |
| quadriceps femoris | UBERON:0001377 | 81.04 | silver quality |
| pigmented layer of retina | UBERON:0001782 | 80.80 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 79.87 | gold quality |
| parietal pleura | UBERON:0002400 | 79.74 | gold quality |
| colonic mucosa | UBERON:0000317 | 79.73 | gold quality |
| jejunum | UBERON:0002115 | 79.17 | gold quality |
| jejunal mucosa | UBERON:0000399 | 78.89 | gold quality |
| gastrocnemius | UBERON:0001388 | 78.76 | gold quality |
| gingival epithelium | UBERON:0001949 | 78.49 | gold quality |
| muscle of leg | UBERON:0001383 | 78.43 | gold quality |
| pancreatic ductal cell | CL:0002079 | 78.38 | silver quality |
| upper arm skin | UBERON:0004263 | 78.34 | gold quality |
| muscle tissue | UBERON:0002385 | 78.11 | gold quality |
| ventricular zone | UBERON:0003053 | 78.05 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.28 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2490.1 | ZFP3 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
140 targeting ZFP3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-4760-3P | 99.93 | 70.50 | 2385 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-6124 | 99.87 | 69.78 | 3551 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-205-5P | 99.81 | 70.05 | 1557 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp3 | ENSMUSG00000043602 |
| rattus_norvegicus | Zfp3 | ENSRNOG00000005009 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 3 homolog — Q96NJ6 (reviewed: Q96NJ6)
Alternative names: Zinc finger protein 752
All UniProt accessions (1): Q96NJ6
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_694563* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050888 | ZnF_C2H2-type_TF | Family |
Pfam: PF00096
UniProt features (20 total): zinc finger region 13, region of interest 2, compositionally biased region 2, cross-link 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96NJ6-F1 | 75.03 | 0.53 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 6, 11
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 77 (showing top):
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, ELK1_01, MARSON_BOUND_BY_FOXP3_STIMULATED, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, FIGUEROA_AML_METHYLATION_CLUSTER_1_UP, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, FIGUEROA_AML_METHYLATION_CLUSTER_4_UP, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN, LIM_MAMMARY_STEM_CELL_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, SNIP1_TARGET_GENES, MIR186_5P
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
290 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP3 | RCVRN | P35243 | 663 |
| ZFP3 | PTGER1 | P34995 | 596 |
| ZFP3 | POLR2L | P52436 | 541 |
| ZFP3 | SPARC | P09486 | 521 |
| ZFP3 | TP53 | P04637 | 519 |
| ZFP3 | SLC46A2 | Q9BY10 | 503 |
| ZFP3 | CRABP2 | P29373 | 446 |
| ZFP3 | RBM6 | P78332 | 432 |
| ZFP3 | RBM27 | Q9P2N5 | 380 |
| ZFP3 | XKR5 | Q6UX68 | 370 |
| ZFP3 | RNF113B | Q8IZP6 | 367 |
| ZFP3 | UBP1 | Q9NZI7 | 331 |
| ZFP3 | K7EJK4 | K7EJK4 | 321 |
| ZFP3 | N4BP3 | O15049 | 316 |
| ZFP3 | ANKRD13D | Q6ZTN6 | 315 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YJU2B | ZFP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP3 | ECE1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| KDR | SMARCA5 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZFP3 | YJU2B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): ZFP3 (Two-hybrid), ZFP3 (Proximity Label-MS), ZFP3 (Proximity Label-MS), ANXA6 (Cross-Linking-MS (XL-MS)), ZFP3 (Affinity Capture-MS), ZFP3 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A6QLU5, O75123, O75820, P10076, P10755, P16374, P17031, P17097, P17141, P51814, Q02975, Q08ER8, Q14588, Q14590, Q32KN0, Q3V080, Q4V8A8, Q5CZA5, Q5R4K8, Q5R5Q6, Q5R9S5, Q5RBX0, Q61751, Q6GQR8, Q6P560, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q7Z3V5, Q8BLB0, Q8N141, Q8N184, Q8N823, Q8N8J6, Q8N9F8, Q8TBZ5, Q8TF47, Q96ND8
Diamond homologs: A1YF12, A1YG88, A2T759, P17020, Q96NJ6, Q1LZ87, Q8NF99, P18715, P18720, P18724, P18729, P18730, P18735, P18737, P18738, P18741, P18743, Q8BLB0, P08045, P18726, P18731, P18736, P18753, P18853, P51815, Q3MJ62, Q3TDE8, Q3US17, Q62513, Q62981, Q6A085, Q6NX45, Q6P1L6, Q7TNU6, Q92670, Q9UEG4, P17023, P17026, P18722, P21506
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
55 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
378 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:5078540:GCGGA:G | donor_gain | 0.9900 |
| 17:5078545:G:GG | donor_gain | 0.9900 |
| 17:5078573:GCG:G | donor_gain | 0.9900 |
| 17:5078572:TGCG:T | donor_loss | 0.9800 |
| 17:5078574:CG:C | donor_loss | 0.9800 |
| 17:5078575:GGTGA:G | donor_loss | 0.9800 |
| 17:5078576:G:GG | donor_gain | 0.9800 |
| 17:5078576:GTGAG:G | donor_loss | 0.9800 |
| 17:5078577:T:TC | donor_loss | 0.9800 |
| 17:5078578:GA:G | donor_loss | 0.9800 |
| 17:5078542:GGA:G | donor_gain | 0.9600 |
| 17:5078543:GA:G | donor_gain | 0.9600 |
| 17:5078543:GAG:G | donor_gain | 0.9600 |
| 17:5078560:G:T | donor_gain | 0.9300 |
| 17:5078579:AGA:A | donor_loss | 0.9300 |
| 17:5091496:GATT:G | acceptor_gain | 0.9200 |
| 17:5078542:G:GT | donor_gain | 0.9100 |
| 17:5091490:ATTTC:A | acceptor_loss | 0.9100 |
| 17:5091491:TTTCA:T | acceptor_loss | 0.9100 |
| 17:5091492:TTCA:T | acceptor_loss | 0.9100 |
| 17:5091493:TCAG:T | acceptor_loss | 0.9100 |
| 17:5091494:CA:C | acceptor_loss | 0.9100 |
| 17:5091495:AGA:A | acceptor_loss | 0.9100 |
| 17:5091496:G:T | acceptor_loss | 0.9100 |
| 17:5078499:C:G | donor_gain | 0.8900 |
| 17:5091495:A:AG | acceptor_gain | 0.8600 |
| 17:5091496:G:GG | acceptor_gain | 0.8600 |
| 17:5078560:G:GT | donor_gain | 0.8500 |
| 17:5078580:G:C | donor_loss | 0.8500 |
| 17:5091701:A:T | donor_gain | 0.8400 |
AlphaMissense
3367 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:5092120:T:C | F206L | 0.999 |
| 17:5092122:C:A | F206L | 0.999 |
| 17:5092122:C:G | F206L | 0.999 |
| 17:5092139:T:C | L212P | 0.999 |
| 17:5092204:T:C | F234L | 0.999 |
| 17:5092206:C:A | F234L | 0.999 |
| 17:5092206:C:G | F234L | 0.999 |
| 17:5092456:T:C | F318L | 0.999 |
| 17:5092458:C:A | F318L | 0.999 |
| 17:5092458:C:G | F318L | 0.999 |
| 17:5091952:T:C | F150L | 0.998 |
| 17:5091954:T:A | F150L | 0.998 |
| 17:5091954:T:G | F150L | 0.998 |
| 17:5092036:T:C | F178L | 0.998 |
| 17:5092038:T:A | F178L | 0.998 |
| 17:5092038:T:G | F178L | 0.998 |
| 17:5092061:G:C | R186P | 0.998 |
| 17:5092288:T:C | F262L | 0.998 |
| 17:5092290:T:A | F262L | 0.998 |
| 17:5092290:T:G | F262L | 0.998 |
| 17:5092307:T:C | L268P | 0.998 |
| 17:5092624:T:C | F374L | 0.998 |
| 17:5092626:C:A | F374L | 0.998 |
| 17:5092626:C:G | F374L | 0.998 |
| 17:5092708:T:C | F402L | 0.998 |
| 17:5092710:C:A | F402L | 0.998 |
| 17:5092710:C:G | F402L | 0.998 |
| 17:5092715:G:C | R404P | 0.998 |
| 17:5092876:T:C | F458L | 0.998 |
| 17:5092878:T:A | F458L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000217058 (17:5079633 T>C), RS1000272444 (17:5086648 T>C), RS1000726620 (17:5079267 A>G), RS1000747607 (17:5091669 G>A,T), RS1000952812 (17:5091295 T>G), RS1001008682 (17:5085242 C>T), RS1001068710 (17:5091068 A>C,G), RS1001576910 (17:5086518 C>T), RS1001728468 (17:5080858 T>C), RS1001737414 (17:5078808 C>G,T), RS1001759758 (17:5080515 C>T), RS1002007935 (17:5086241 T>A), RS1002122026 (17:5077483 G>A), RS1002495878 (17:5089716 C>G,T), RS1002609278 (17:5087705 C>T)
Disease associations
OMIM: gene MIM:194480 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004744_24 | Lung adenocarcinoma | 5.000000e-06 |
| GCST007540_10 | PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia | 5.000000e-06 |
| GCST90013442_27 | Keratoconus | 2.000000e-14 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004881 | asparaginase hypersensitivity |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066430 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 5.52 | Kd | 3008 | nM | CHEMBL5653589 |
| 5.52 | ED50 | 3008 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149810: Binding affinity to human ZFP3 incubated for 45 mins by Kinobead based pull down assay | kd | 3.0078 | uM |
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, increases expression | 4 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| manganese chloride | decreases expression, increases abundance | 1 |
| beta-methylcholine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Manganese | decreases expression, increases abundance | 1 |
| Rotenone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652852 | Binding | Binding affinity to human ZFP3 incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD05 | HEK293 eGFP-ZFP3 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): keratoconus, lung adenocarcinoma